A comparison of fluvastatin 40 mg every other day versus 20 mg every day in patients with hypercholesterolemia

Pharmacotherapy. 1998 Jul-Aug;18(4):836-9.

Abstract

Study objective: To assess the efficacy of fluvastatin administered every other day versus an equivalent dose given daily in patients with hypercholesterolemia.

Design: Randomized, nonblinded, crossover study.

Setting: Veterans Affairs Medical Center.

Patients: Twenty-three patients with low-density lipoprotein (LDL) levels above 160 mg/dl despite diet therapy

Intervention: Patients received fluvastatin 40 mg every other day or 20 mg/day, all doses taken at bedtime. Each treatment arm was 6 weeks in duration.

Measurements and main results: A lipid profile was determined at baseline and after each regimen. Both regimens significantly lowered total cholesterol and LDL versus baseline. The LDL levels were lowered by 24% and 21% by fluvastatin 20 mg/day and 40 mg every other day, respectively. There was no statistically significant difference in lipid components between regimens.

Conclusion: Fluvastatin 40 mg every other day is effective in lowering total cholesterol and LDL in patients with hypercholesterolemia.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Anticholesteremic Agents / administration & dosage*
  • Anticholesteremic Agents / adverse effects
  • Anticholesteremic Agents / therapeutic use*
  • Cholesterol / blood
  • Cross-Over Studies
  • Dose-Response Relationship, Drug
  • Fatty Acids, Monounsaturated / administration & dosage*
  • Fatty Acids, Monounsaturated / adverse effects
  • Fatty Acids, Monounsaturated / therapeutic use*
  • Female
  • Fluvastatin
  • Gastrointestinal Diseases / chemically induced
  • Humans
  • Hypercholesterolemia / drug therapy*
  • Indoles / administration & dosage*
  • Indoles / adverse effects
  • Indoles / therapeutic use*
  • Lipoproteins, LDL / blood
  • Lipoproteins, LDL / drug effects
  • Liver / drug effects
  • Liver / physiopathology
  • Liver Function Tests
  • Male
  • Middle Aged
  • Treatment Outcome
  • Urinary Retention / chemically induced

Substances

  • Anticholesteremic Agents
  • Fatty Acids, Monounsaturated
  • Indoles
  • Lipoproteins, LDL
  • Fluvastatin
  • Cholesterol